# YTS109 in Pediatric Relapsed/Refractory Autoimmune Diseases

> **NCT07439029** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Children's Hospital of Fudan University** · enrollment: 12 (estimated)

## Conditions studied

- Systemic Lupus Erythematosus (SLE)
- Diffuse Systemic Sclerosis
- Idiopathic Inflammatory Myopathies (IIMs)
- ANCA Associated Vasculitis (AAV)
- Antiphospholipid Syndrome (APS)
- Sjogren's Syndrome (SS)

## Interventions

- **BIOLOGICAL:** YTS109 cell
- **OTHER:** YTS109 cell

## Key facts

- **NCT ID:** NCT07439029
- **Lead sponsor:** Children's Hospital of Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03
- **Primary completion:** 2027-03
- **Final completion:** 2030-07
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-02-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07439029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07439029, "YTS109 in Pediatric Relapsed/Refractory Autoimmune Diseases". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT07439029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*